904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-11-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| _version_ | 1818969480735227904 |
|---|---|
| author | Thomas Mace Gregory Lesinski Chrystal Paulos Megan Wyatt Cameron Herting Michael Ware Juan Sarmiento Shishir Maithel Bassel El-rayes Maggie Phillips |
| author_facet | Thomas Mace Gregory Lesinski Chrystal Paulos Megan Wyatt Cameron Herting Michael Ware Juan Sarmiento Shishir Maithel Bassel El-rayes Maggie Phillips |
| author_sort | Thomas Mace |
| collection | DOAJ |
| first_indexed | 2024-12-20T14:21:16Z |
| format | Article |
| id | doaj.art-626cf3db491d42baaac75a0a5857e903 |
| institution | Directory Open Access Journal |
| issn | 2051-1426 |
| language | English |
| last_indexed | 2024-12-20T14:21:16Z |
| publishDate | 2021-11-01 |
| publisher | BMJ Publishing Group |
| record_format | Article |
| series | Journal for ImmunoTherapy of Cancer |
| spelling | doaj.art-626cf3db491d42baaac75a0a5857e9032022-12-21T19:37:55ZengBMJ Publishing GroupJournal for ImmunoTherapy of Cancer2051-14262021-11-019Suppl 210.1136/jitc-2021-SITC2021.904904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinomaThomas Mace0Gregory Lesinski1Chrystal Paulos2Megan Wyatt3Cameron Herting4Michael Ware5Juan Sarmiento6Shishir Maithel7Bassel El-rayes8Maggie Phillips9Aff1 grid.261331.40000000122857943The Ohio State University Columbus OH USA1Winship Cancer Institute of Emory University, Decatur, GA, USA1Emory University, Atlanta, GA, USA1Emory University, Atlanta, GA, USA1Winship Cancer Institute of Emory University, Decatur, GA, USA1Winship Cancer Institute of Emory University, Decatur, GA, USA1Winship Cancer Institute of Emory University, Decatur, GA, USA1Winship Cancer Institute of Emory University, Decatur, GA, USA1Winship Cancer Institute of Emory University, Decatur, GA, USAMedical director Travellers` Medical and Vaccination Centre, Adelaide, Australia |
| spellingShingle | Thomas Mace Gregory Lesinski Chrystal Paulos Megan Wyatt Cameron Herting Michael Ware Juan Sarmiento Shishir Maithel Bassel El-rayes Maggie Phillips 904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma Journal for ImmunoTherapy of Cancer |
| title | 904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
| title_full | 904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
| title_fullStr | 904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
| title_full_unstemmed | 904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
| title_short | 904 Repurposing CD26 (DPP4) inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
| title_sort | 904 repurposing cd26 dpp4 inhibitors to enhance immunotherapy response in pancreatic ductal adenocarcinoma |
| work_keys_str_mv | AT thomasmace 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT gregorylesinski 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT chrystalpaulos 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT meganwyatt 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT cameronherting 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT michaelware 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT juansarmiento 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT shishirmaithel 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT basselelrayes 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma AT maggiephillips 904repurposingcd26dpp4inhibitorstoenhanceimmunotherapyresponseinpancreaticductaladenocarcinoma |